Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga)
Journal of Ayurveda and Integrated Medical Sciences · 14.03.2026 · 11 (2) · 281-291
DOI: 10.21760/jaims.11.2.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 14.03.2026. Verfasst von Preetam Sahu und 4 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non-Alcoholic Fatty Liver Disease (NAFLD) has become a global health challenge and a leading cause of chronic liver dysfunction, closely associated with obesity, insulin resistance, and metabolic syndrome. Characterized by excessive hepatic fat accumulation without significant alcohol consumption, NAFLD is now recognized as the hepatic manifestation of systemic metabolic imbalance. Despite its high prevalence, modern medicine lacks a definitive pharmacological treatment, relying largely on lifestyle and dietary interventions. Ayurveda, the traditional Indian system of medicine, offers a holistic and individualized approach to metabolic disorders through the principles of Agni (digestive fire), Doṣa balance, and Dhātu Samya (tissue homeostasis).
Objective
This review aims to explore the conceptual understanding of NAFLD in the Ayurvedic framework of Yakṛt Roga and Medoroga, and to evaluate the therapeutic potential of Pañchakarma (biopurification therapies) and Āhāra Parivarjana (dietary regulation) in its prevention and management. Methodology: A comprehensive review of classical Ayurvedic texts including Charaka Saṃhitā, Suśruta Saṃhitā, and Aṣṭāṅga Hṛdaya was conducted to identify references related to Yakṛt Roga and Medoroga. Contemporary scientific literature from PubMed, AYUSH Research Portal, and integrative medicine journals was also examined to correlate Ayurvedic therapeutic principles with modern hepatological concepts. Clinical trials and pharmacological studies evaluating Ayurvedic drugs and Panchakarma procedures in hepatic disorders were critically analyzed.
Results
The Ayurvedic pathogenesis of NAFLD can be correlated with Agni-māndya (metabolic insufficiency) leading to Āma (toxic intermediate metabolites) and Meda Dhātu Dushti (abnormal fat metabolism). Panchakarma therapies such as Virechana (therapeutic purgation), Lekhana Basti (fat-reducing medicated enema), and Rasāyana (rejuvenation therapy) effectively eliminate accumulated Doṣas, enhance metabolic activity, and promote hepatic regeneration. Modern research supports that these therapies improve liver enzymes (ALT, AST), lipid profiles, and reduce hepatic steatosis. Āhāra Parivarjana, emphasizing Kapha–Pitta-pacifying, Laghu (light), Tikta–Katu–Kaṣāya (bitter, pungent, astringent) diets, helps restore Agni, prevent further fat deposition, and sustain post-Panchakarma equilibrium. Foods such as barley, green gram, bottle gourd, Amla, Triphalā, and condiments like turmeric and ginger demonstrate hepatoprotective, antioxidant, and lipid-regulating effects, paralleling modern nutritional recommendations for NAFLD.
Conclusion
Ayurveda offers a comprehensive, evidence-based approach to NAFLD through the synergistic application of Pañchakarma and Āhāra Parivarjana. This dual therapy not only detoxifies and rejuvenates the liver but also reinstates the harmony of Agni and metabolism, offering long-term disease reversal and systemic health restoration. Integrating these Ayurvedic modalities into contemporary hepatology can provide a safe, personalized, and sustainable therapeutic model for managing Non-Alcoholic Fatty Liver Disease.
Zitieren
APA
Sahu, P., Zala, M., Saini, N., Koodur, S., & Singh, T. (2026). Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga). Journal of Ayurveda and Integrated Medical Sciences, 11(2), 281-291. https://doi.org/10.21760/jaims.11.2.44
Vancouver
Sahu P, Zala M, Saini N, Koodur S, Singh T. Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga). Journal of Ayurveda and Integrated Medical Sciences. 2026;11(2):281-291. doi:10.21760/jaims.11.2.44
BibTeX
@article{Sahu2026,
author = {Sahu, Preetam and Zala, Minaxi and Saini, Neha and Koodur, Sudhanva and Singh, Tejendra},
title = {Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga)},
journal = {Journal of Ayurveda and Integrated Medical Sciences},
year = {2026},
volume = {11},
number = {2},
pages = {281--291},
doi = {10.21760/jaims.11.2.44}
}
EUVIMED